- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Candida albicans and Antifungal Peptides ; volume:12 ; number:12 ; day:8 ; month:11 ; year:2023 ; pages:2631-2648 ; date:12.2023
Infectious diseases and therapy ; 12, Heft 12 (8.11.2023), 2631-2648, 12.2023
- Urheber
-
Freitas, Camila G.
Felipe, Maria Sueli
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-023-00889-9
- URN
-
urn:nbn:de:101:1-2024030721123487485673
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Freitas, Camila G.
- Felipe, Maria Sueli
- SpringerLink (Online service)
Ähnliche Objekte (12)
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Antifungal activity of MAF-1A peptide against Candida albicans
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans
Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Antifungal activity of MAF-1A peptide against Candida albicans
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans
Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A
Targeting Candida albicans O-acetyl-L-homoserine sulfhydrylase (Met15p) in antifungal treatment
Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida
Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
Antifungal activity of MAF-1A peptide against Candida albicans
Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species
Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans
Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
Antifungal Activity of Synthetic Scorpion Venom-Derived Peptide Analogues Against Candida albicans
Evolution of antifungal drug resistance of the human-pathogenic fungus Candida albicans
The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A